Thermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation Proteomics
Go back to Thermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation Proteomics| (NASDAQ: OLK) | Delayed: 26.08 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.08 | 52 Week High | $ | |||
| Open | $26.08 | 52 Week Low | $ | |||
| Day High | $26.08 | P/E | N/A | |||
| Day Low | $26.08 | EPS | $ | |||
| Volume | 1,000 | |||||
| Thermo Fisher Scientific (NYSE: TMO) | Delayed: 629.27 +1.72 (0.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $627.55 | 52 Week High | $160.68 | |||
| Open | $626.48 | 52 Week Low | $119.75 | |||
| Day High | $629.51 | P/E | 179.79 | |||
| Day Low | $616.27 | EPS | $3.50 | |||
| Volume | 1,556,078 | |||||

